Literature DB >> 16307347

Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats.

Meltem Kuruş1, Mukaddes Eşrefoğlu, Aysun Bay, Feral Oztürk.   

Abstract

BACKGROUND: One of the major adverse effects of long term cyclosporine A (CyA) administration is chronic nephrotoxicity. Several studies have suggested that alterations of the L-arginine (L-Arg) nitric oxide (NO) pathway may be involved in the pathogenesis of CyA-induced kidney damage. AIM: We postulated that in vivo activation of L-Arg-NO pathway might have a beneficial effect on CyA-induced renal damage. Conditions of chronic NO enhancement was established with L-Arg supplementation and chronic NO blockade with N-nitro-L-Arg methyl ester (L-NAME). We tested the hypothesis that, if CyA administration alters intrarenal NO synthesis, then exogenous L-Arg supplementation could limit renal injury, on the contrary, L-NAME, a potent competitive inhibitor of NO synthesis, could enhance CyA nephrotoxicity. Harmful effect of NO blockade indirectly supports the beneficial effect of NO in a model of CyA nephrotoxicity.
METHODS: Rats were administered vehicle (VH), CyA (7.5 mg/kg/day), CyA + L-Arg (2g/kg/day), CyA + L-NAME (5 mg/100 ml/day), CyA + L-Arg + L-NAME, VH + L-Arg, VH + L-NAME and were sacrificed at the end of the experiment. Body weight, serum creatinine, blood urea nitrogen (BUN) and NO levels were determined. Tubular injury and interstitial fibrosis were evaluated semiquantitatively using scoring systems on paraffin sections stained with hematoxylin/eosin (H/E), Masson's trichromic and periodic acid-Schiff (PAS).
RESULTS: The CyA group developed marked renal injury, characterized by a significant increase in serum creatinine and BUN, and histopathological alterations including tubular dilatation, vacuolization, necrosis, interstitial cell infiltration and tubulointerstitial fibrosis. CyA reduced serum NO level. L-Arg treatment significantly enhanced NO biosynthesis and protected animals from CyA-induced kidney damage. In contrast L-NAME strikingly reduced serum NO level, and worsened biochemical and histopathological alterations.
CONCLUSION: Chronic CyA nephrotoxicity can be aggravated by NO blockade and ameliorated by NO enhancement suggesting that L-Arg supplementation may be protective in CyA nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307347     DOI: 10.1007/s11255-004-0011-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  29 in total

1.  Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.

Authors:  F S Shihab; T F Andoh; A M Tanner; N A Noble; W A Border; N Franceschini; W M Bennett
Journal:  Kidney Int       Date:  1996-04       Impact factor: 10.612

2.  Protective effect of oral L-arginine administration on gentamicin-induced renal failure in rats.

Authors:  C Can; S Sen; N Boztok; I Tuglular
Journal:  Eur J Pharmacol       Date:  2000-03-03       Impact factor: 4.432

3.  Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.

Authors:  F S Shihab; W M Bennett; A M Tanner; T F Andoh
Journal:  Kidney Int       Date:  1997-09       Impact factor: 10.612

Review 4.  Nitric oxide in renal health and disease.

Authors:  B C Kone
Journal:  Am J Kidney Dis       Date:  1997-09       Impact factor: 8.860

5.  Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.

Authors:  F S Shihab; T F Andoh; A M Tanner; W M Bennett
Journal:  Am J Kidney Dis       Date:  1997-07       Impact factor: 8.860

6.  Beneficial and harmful effects of L-arginine on renal ischaemia.

Authors:  L A Tomé; L Yu; I de Castro; S B Campos; A C Seguro
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

7.  Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.

Authors:  O G Pankewycz; L Miao; R Isaacs; J Guan; T Pruett; G Haussmann; B C Sturgill
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

8.  Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition.

Authors:  M P Gardner; D C Houghton; T F Andoh; J Lindsley; W M Bennett
Journal:  Transplantation       Date:  1996-05-27       Impact factor: 4.939

9.  Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine.

Authors:  Z Zhong; G E Arteel; H D Connor; M Yin; M V Frankenberg; R F Stachlewitz; J A Raleigh; R P Mason; R G Thurman
Journal:  Am J Physiol       Date:  1998-10

Review 10.  Cytokines and L-arginine in renal injury and repair.

Authors:  M Ketteler; W A Border; N A Noble
Journal:  Am J Physiol       Date:  1994-08
View more
  2 in total

1.  Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant.

Authors:  Kiran Bambha; W Ray Kim; Charles B Rosen; Rachel A Pedersen; Cynthia Rys; Christopher P Kolbert; Julie M Cunningham; Terry M Therneau
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

2.  Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy.

Authors:  Inès Jadot; Vanessa Colombaro; Blanche Martin; Isabelle Habsch; Olivia Botton; Joëlle Nortier; Anne-Emilie Declèves; Nathalie Caron
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.